The Chosun Ilbo on MSN
Kim V Narry wins Nakasone Award for mRNA breakthrough
Kim V. Narry, 57 years old, head of the Institute for Basic Science (IBS) RNA Research Group and a distinguished professor at ...
A new Lancet review concludes that mRNA COVID-19 vaccines neither persist indefinitely in the body nor become part of our DNA ...
A new Northwestern Medicine study published in the Proceedings of the National Academy of Sciences has explored the impacts ...
Korea Joongang Daily on MSN
Korean RNA pioneer becomes the first Korean recipient of the Nakasone Award
Professor Kim V. Narry became the first Asian scientist to receive the HFSP Nakasone Award for RNA discoveries that helped ...
Researchers reviewed laboratory, clinical, and real-world data on mRNA vaccines. They confirmed safety and effectiveness and ...
Messenger RNA (mRNA) vaccines are one of the biggest medical breakthroughs of recent years. It was first introduced during ...
Lunchtime idea evolves into potential mRNA therapy for intractable diseases, joy in recognition of pioneering field ...
RNA has emerged as one of the most promising molecules in modern medicine, enabling advances from mRNA vaccines and gene ...
Learn how mRNA vaccines work, why serious risks remain rare, and how the technology could be used beyond COVID-19.
Proprietary Synthetic Polynucleotide Platform Accelerates Non-Viral, Footprint-Free Induced Pluripotent Stem Cell Generation Amid Surging Commercialization of iPSC Therapies in JapanSEATTLE, June 16, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results